Corder M P, Stone W H
Cancer. 1976 Apr;37(4):1660-2. doi: 10.1002/1097-0142(197604)37:4<1660::aid-cncr2820370407>3.0.co;2-j.
A 21-year-old patient with metastatic osteosarcoma was receiving methotrexate with leucovorin rescue every 2 weeks. After the second (of four) infusions of methotrexate, a prior solar burn on an area of skin was reactivated in spite of leucovorin rescue. An area of skin treated 5 months previously by radiation was spared the effects of the reactivation phenomenon. No other toxicities appeared. The reactivation of the solar burn is an example of "false photosensitization" and this cutaneous toxicity is not ameliorated by leucovorin. Methotrexate therapy should be delayed until the effects of generalized solar burns have resolved (approximately 1 week).
一名21岁的转移性骨肉瘤患者每2周接受一次甲氨蝶呤治疗并使用亚叶酸钙解救。在(四次中的)第二次甲氨蝶呤输注后,尽管有亚叶酸钙解救,先前一处皮肤的日晒伤仍被重新激活。5个月前接受过放射治疗的皮肤区域未出现重新激活现象的影响。未出现其他毒性反应。日晒伤的重新激活是“假性光敏化”的一个例子,这种皮肤毒性不会因亚叶酸钙而改善。甲氨蝶呤治疗应推迟至全身性日晒伤的影响消退(约1周)。